Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721499 · ClinicalTrials.gov registry record · Phase 1
Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training
A Phase 1 study of Obesity and Stress, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT01721499: Completed Phase 1 study of Obesity and Stress, sponsored by Yale University.
NCT01721499 is a Phase 1 study of Obesity and Stress that has completed, run by Yale University. The registered enrollment target is 112 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721499, a Phase 1 study of Obesity and Stress, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study of treatment approaches aimed to improve self-control and decrease stress and unhealthy/maladaptive behaviors such as drinking, overeating, and smoking. High levels of stress may make it harder to maintain self-control, especially when trying to control our unhealthy behaviors. Training on improving self control and decreasing stress may help decrease unhealthy behaviors. The goal of this new training program will be to decrease a subject's unhealthy behavior by helping them better manage their stress and improve their self control over unhealthy habits.
Primary Outcome
Develop a mindfulness based affect-regulation therapy manual, and training materials to train therapists on a treatment approach aimed at improving self-control over unhealthy addictive behaviors.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Intervention
- BEHAVIORAL Nutritional Counseling
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
What the finished NCT01721499 record still lists
NCT01721499 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Intervention is the first listed.
NCT01721499 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01721499 about?
NCT01721499 is a clinical study titled "Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training". This is a study of treatment approaches aimed to improve self-control and decrease stress and unhealthy/maladaptive behaviors such as drinking, overeating, and smoking. High levels of stress may make it harder to maintain self-control, especially when trying to control our unhealthy behaviors. Trai...
What is the current status of trial NCT01721499?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 112 participants. The study started on 2010-09. Estimated completion is 2013-01.
What conditions does trial NCT01721499 study?
This clinical trial studies the following conditions: Obesity, Stress, Overeating.
What interventions are being tested in trial NCT01721499?
The interventions under investigation include: Mindfulness Intervention (BEHAVIORAL), Nutritional Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01721499?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01721499 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01721499's enrollment target sits among peer trials
112 456th of 1053 higher than 598 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
RECRUITING · Phase 1
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
-
A Study of LY3971297 in Healthy Participants
RECRUITING · Phase 1
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia